Epidemic Retinitis with Positive or Negative Weil Felix Test - a Comparative Study and Outcome with Doxycycline
PURPOSE: To compare clinical manifestations and disease outcomes in Epidemic Retinitis (ER) with positive or negative Weil Felix Test (WFT).
METHODS: Retrospective, observational, comparative study. WFT positive or negative patients formed Group 1 and 2, respectively. Patients receiving oral doxycycline monotherapy formed subgroup A and B. Duration of resolution of macular edema and retinitis was compared.
RESULTS: Novel finding of "ring retinitis" was observed equally in group 1 and 2. Complete resolution of macular edema took 41.3 days (range: 30-60 days) and 43.68 days (range: 20-105 days) (p = .668) and retinitis lesions resolved in 34.3 days (range: 14-65 days) and 34 days (range: 12-60 days) (p = .875) in group A and B, respectively. All (n = 14) eyes with retinitis within 1 disc diameter of fovea improved better than 20/80 except 1.
CONCLUSION: No significant difference with respect to clinical, imaging findings and the treatment outcome was observed in WFT positive or negative cases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Ocular immunology and inflammation - 30(2022), 7-8 vom: 02. Okt., Seite 1582-1587 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kawali, Ankush [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-VEGF |
---|
Anmerkungen: |
Date Completed 15.12.2022 Date Revised 15.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09273948.2021.1909072 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM325548706 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM325548706 | ||
003 | DE-627 | ||
005 | 20231225192658.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09273948.2021.1909072 |2 doi | |
028 | 5 | 2 | |a pubmed24n1085.xml |
035 | |a (DE-627)NLM325548706 | ||
035 | |a (NLM)34003725 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kawali, Ankush |e verfasserin |4 aut | |
245 | 1 | 0 | |a Epidemic Retinitis with Positive or Negative Weil Felix Test - a Comparative Study and Outcome with Doxycycline |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.12.2022 | ||
500 | |a Date Revised 15.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a PURPOSE: To compare clinical manifestations and disease outcomes in Epidemic Retinitis (ER) with positive or negative Weil Felix Test (WFT) | ||
520 | |a METHODS: Retrospective, observational, comparative study. WFT positive or negative patients formed Group 1 and 2, respectively. Patients receiving oral doxycycline monotherapy formed subgroup A and B. Duration of resolution of macular edema and retinitis was compared | ||
520 | |a RESULTS: Novel finding of "ring retinitis" was observed equally in group 1 and 2. Complete resolution of macular edema took 41.3 days (range: 30-60 days) and 43.68 days (range: 20-105 days) (p = .668) and retinitis lesions resolved in 34.3 days (range: 14-65 days) and 34 days (range: 12-60 days) (p = .875) in group A and B, respectively. All (n = 14) eyes with retinitis within 1 disc diameter of fovea improved better than 20/80 except 1 | ||
520 | |a CONCLUSION: No significant difference with respect to clinical, imaging findings and the treatment outcome was observed in WFT positive or negative cases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Epidemic retinitis | |
650 | 4 | |a Weil Felix Test | |
650 | 4 | |a anti-VEGF | |
650 | 4 | |a doxycycline | |
650 | 4 | |a post-fever retinitis | |
650 | 4 | |a rickettsial retinitis | |
650 | 4 | |a ring retinitis | |
650 | 4 | |a steroid | |
650 | 4 | |a treatment outcome | |
700 | 1 | |a Mahendradas, Padmamalini |e verfasserin |4 aut | |
700 | 1 | |a Sanjay, Srinivasan |e verfasserin |4 aut | |
700 | 1 | |a Mohan, Ashwin |e verfasserin |4 aut | |
700 | 1 | |a Shetty, Bhujang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ocular immunology and inflammation |d 1993 |g 30(2022), 7-8 vom: 02. Okt., Seite 1582-1587 |w (DE-627)NLM091014069 |x 1744-5078 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2022 |g number:7-8 |g day:02 |g month:10 |g pages:1582-1587 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09273948.2021.1909072 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2022 |e 7-8 |b 02 |c 10 |h 1582-1587 |